|
|
Prepublished online as a Blood First Edition Paper on July 3, 2003; DOI 10.1182/blood-2002-12-3826.

Submitted December 18, 2002
Accepted June 12, 2003
Over expression of the Notch ligand, Jagged-1 induces alloantigen-specific human regulatory T cells
Eric S Yvon, Stephane Vigouroux, Raphael F Rousseau, Ettore Biagi, Persis Amrolia, Gianpietro Dotti, Hans-Joachim Wagner, and Malcolm K Brenner*
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA
* Corresponding author; email: mbrenner{at}bcm.tmc.edu.
Graft-versus-host disease (GvHD) represents one of the major complications of allogeneic hematopoietic stem cell transplantation. Techniques to prevent GvHD have included ex-vivo T cell depletion of the graft or prolonged in vivo immunosuppression. Both reduce the frequency and severity of GvHD but also reduce T cell mediated graft-versus-malignancy effect, and increase the risk of infection. A major goal in transplantation is to prevent alloreactivity whilst preserving activity against tumors and infectious agents. We have used activation of the Notch pathway to try to generate T cells able to specifically regulate alloantigen responses. We used allogeneic EBV-lymphoblastoid B cells (EBV-LCL) as stimulator cells. Such LCLs are excellent (allo)-antigen presenting cells and can be obtained in large numbers even from donors who have received extensive chemo/radiotherapy. We overexpressed a Notch-ligand, Jagged-1 in these cells by adenoviral vector transduction. Stimulation of CD45RA+ naive T cells by Jagged-1 reduces production of interferon-g, interleukin-2 and interleukin-5, but upregulates Transforming Growth Factor-b1 synthesis, consistent with induction of a regulatory T cell phenotype. Transfer of these cells to fresh lymphocyte cultures inhibits proliferative and cytotoxic immune responses to the priming alloantigens whilst sparing responses to third party stimulator cells. Notch activation in the presence of alloantigen presenting cells may therefore be a means of inducing specific regulatory T cells whilst preserving other T cell functionality.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M.-T. Huang, Y.-S. Dai, Y.-B. Chou, Y.-H. Juan, C.-C. Wang, and B.-L. Chiang
Regulatory T Cells Negatively Regulate Neovasculature of Airway Remodeling via DLL4-Notch Signaling
J. Immunol.,
October 1, 2009;
183(7):
4745 - 4754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Yvon, M. Del Vecchio, B. Savoldo, V. Hoyos, A. Dutour, A. Anichini, G. Dotti, and M. K. Brenner
Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
Clin. Cancer Res.,
September 15, 2009;
15(18):
5852 - 5860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-L. Zhang, J. Peng, J.-Z. Sun, J.-J. Liu, C.-S. Guo, Z.-G. Wang, Y. Yu, Y. Shi, P. Qin, S.-G. Li, et al.
De novo induction of platelet-specific CD4+CD25+ regulatory T cells from CD4+CD25- cells in patients with idiopathic thrombocytopenic purpura
Blood,
March 12, 2009;
113(11):
2568 - 2577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Zhang, R. Liu, D. Shi, X. Liu, Y. Chen, X. Dou, X. Zhu, C. Lu, W. Liang, L. Liao, et al.
Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population
Blood,
January 1, 2009;
113(1):
46 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rutz, M. Janke, N. Kassner, T. Hohnstein, M. Krueger, and A. Scheffold
Notch regulates IL-10 production by T helper 1 cells
PNAS,
March 4, 2008;
105(9):
3497 - 3502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Asano, T. Watanabe, A. Kitani, I. J. Fuss, and W. Strober
Notch1 Signaling and Regulatory T Cell Function
J. Immunol.,
March 1, 2008;
180(5):
2796 - 2804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chen, B. Zhao, E. Kieff, J. C. Aster, and F. Wang
EBNA-3B- and EBNA-3C-Regulated Cellular Genes in Epstein-Barr Virus-Immortalized Lymphoblastoid Cell Lines.
J. Virol.,
October 1, 2006;
80(20):
10139 - 10150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rutella, S. Danese, and G. Leone
Tolerogenic dendritic cells: cytokine modulation comes of age
Blood,
September 1, 2006;
108(5):
1435 - 1440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Biagi, R. Rousseau, E. Yvon, M. Schwartz, G. Dotti, A. Foster, D. Havlik-Cooper, B. Grilley, A. Gee, K. Baker, et al.
Responses to Human CD40 Ligand/Human Interleukin-2 Autologous Cell Vaccine in Patients with B-Cell Chronic Lymphocytic Leukemia
Clin. Cancer Res.,
October 1, 2005;
11(19):
6916 - 6923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Fehervari and S. Sakaguchi
CD4+ regulatory cells as a potential immunotherapy
Phil Trans R Soc B,
September 29, 2005;
360(1461):
1647 - 1661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Worgall, A. Heguy, K. Luettich, T. P. O'Connor, B.-G. Harvey, L. E. N. Quadri, and R. G. Crystal
Similarity of Gene Expression Patterns in Human Alveolar Macrophages in Response to Pseudomonas aeruginosa and Burkholderia cepacia
Infect. Immun.,
August 1, 2005;
73(8):
5262 - 5268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Anderson, E. A. Kitchens, S. W. Chan, C. St. Hill, Y. N. Jan, W. Zhong, and E. A. Robey
The Notch Regulator Numb Links the Notch and TCR Signaling Pathways
J. Immunol.,
January 15, 2005;
174(2):
890 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-i. Tsukumo and K. Yasutomo
Notch Governing Mature T Cell Differentiation
J. Immunol.,
December 15, 2004;
173(12):
7109 - 7113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vigouroux, E. Yvon, E. Biagi, and M. K. Brenner
Antigen-induced regulatory T cells
Blood,
July 1, 2004;
104(1):
26 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Sumpter and D. S. Wilkes
Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection
Am J Physiol Lung Cell Mol Physiol,
June 1, 2004;
286(6):
L1129 - L1139.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|